Bgm Group Ltd (BGM) Return on Equity ROE from the fourth quarter 2024 to fourth quarter 2023 and annually, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bgm Group Ltd  (BGM)

Bgm Group Ltd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Bgm Group Ltd in the fourth quarter 2024?
Bgm Group Ltd recorded a cumulative net loss of $-2 million during 12 months ending in the fourth quarter 2024, resulting in a negative return on equity (ROE) of -0.92%.

Within the Major Pharmaceutical Preparations industry 55 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2024 from 0 to 2318.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2023)
IV. Quarter
Y / Y Equity Change 788.79 % 310.64 % -0.58 % -3.62 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -2 -8 -8 -8 -8
Return On Equity (TTM) -0.92 % -10.38 % -18.53 % -18.51 % -18.34 %
BGM's Total Ranking # 2318 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 392 182 44 43 44
Seq. Equity Change 115.18 % 313.04 % 3.16 % -3.06 % -0.58 %
Seq. Net Income Change - - - - -

Back to BGM Management Effectiveness >> BGM's 5 Years Annual ROE >> Compare BGM ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 56
Sector # 191
Overall # 2318

Return On Equity Statistics
High Average Low
5.56 %
1.06 %
-3.44 %
(Sep 30 2021)   (Sep 30 2024)





BGM Annual Return On Equity (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Equity in Millions 392 43 44 55 57
Y / Y Equity Change 816.85 % -3.62 % -19.31 % -3.01 % 96.48 %
Net Income in Millions -20 -2 -8 1 3
Y / Y Net Income Change - - - -56.04 % -37.09 %
Return On Equity -5.16 % -3.55 % -18.31 % 2.49 % 5.48 %

Back to BGM Management Effectiveness >> BGM's 5 Years Annual ROE >> Compare BGM ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BGM's' Return on Equity at Yahoo Finance
BGM's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BGM's Competitors
Subscribers only: Roe for Bgm Group Ltd's Suppliers
Subscribers only: Return On Equity for BGM's Customers




Companies with similar Return On Equity at Sep 30 2024, within Healthcare Sector ROE

Date modified: 2026-09-08T15:11:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.